Clinical Trial Update: Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of pertuzumab plus trastuzumab and nab-paclitaxel (albumin-stabilized nanoparticle paclitaxel) for HER2-positive advanced breast cancer, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: HER2-positive Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-06-28